Atlas Trials

Safety and Efficacy of Apligraf in Nonhealing Wounds of Subjects With Junctional or Dystrophic Epidermolysis Bullosa (EB)

Clinical trial NCT00587223 · TERMINATED

Trial details

NCT number
NCT00587223
Sponsor
Organogenesis
Status
TERMINATED
Phase
Phase 3
Study type
INTERVENTIONAL
Epidermolysis Bullosa, JunctionalEpidermolysis Bullosa Dystrophica
Start date
2007-12-01
Primary completion
2008-12-01
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.